Open study of pranlukast add-on therapy in intractable partial epilepsy

Abstract Innovative treatments of epileptic seizures are needed to improve the outcome of epilepsy. We studied the effect of pranlukast on seizure outcome in patients with intractable partial epilepsy. An open study was conducted to evaluate the clinical efficacy of 24-week pranlukast add-on therapy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Brain & development (Tokyo. 1979) 2013-03, Vol.35 (3), p.236-244
Hauptverfasser:	Takahashi, Yukitoshi, Imai, Katsumi, Ikeda, Hitoshi, Kubota, Yuko, Yamazaki, Etsuko, Susa, Fuminobu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Anticonvulsants - therapeutic use Biomarkers - blood Biomarkers - cerebrospinal fluid CD4-Positive T-Lymphocytes - physiology Cell Count Child Chromones - therapeutic use Cytokines Cytokines - cerebrospinal fluid Drug Resistance Drug Therapy, Combination Epilepsies, Partial - drug therapy Epilepsy Female Humans Interleukin-1beta - cerebrospinal fluid Interleukin-6 - cerebrospinal fluid Leukotriene Antagonists - therapeutic use Male Matrix Metalloproteinase 9 - metabolism Matrix metalloproteinase-9 Neurology Pranlukast Receptors, Tumor Necrosis Factor, Type I - cerebrospinal fluid Seizures - prevention & control T-Lymphocytes - physiology Treatment Outcome Tumor Necrosis Factor-alpha - cerebrospinal fluid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!